2.1.2.2	diagnostics	GART expression is associated with glioma grade and high GART protein expression might be related to poor outcome	736945	
2.1.2.2	diagnostics	increased expression of glycinamide ribonucleotide transformylase is associated with a poor prognosis in hepatocellular carcinoma	736225	
2.1.2.2	medicine	-	485731, 485735, 485737	
2.1.2.2	medicine	glycinamide ribonucleotide transformylase has emerged as a productive target for antineoplastic therapeutic intervention	688291	
2.1.2.2	medicine	glycinamide ribonucleotide transformylase is a validated target for cancer chemotherapy	685128	
2.1.2.2	medicine	high GART expression is observed in glioma and is related to the grade of malignancy. GART overexpression is significantly associated with overall survival. Transfecting cells with GART-siRNA suppresses proliferation and enhances temozolomide-induced apoptosis in glioma cells	745966	
2.1.2.2	medicine	inhibitor 5,10-dideazatetrahydrofolate is antiproliferate and cytotoxic against mammalian tumor cells in culture and have broad spectrum activity against transplantable mouse tumors and human tumor xenografts	485731, 485737	
2.1.2.2	medicine	pharmacological importance, target enzyme for chemotherapy, development of novel antifolate drugs, to be used as anti-cancer drugs	485715, 485719, 485724, 485725, 485734, 485738, 485740, 485741	
2.1.2.2	medicine	target for structure-based drug design	485719